AU2008248475B2 - Derivatives of the aminated hydroxyquinoline class for treating cancers - Google Patents

Derivatives of the aminated hydroxyquinoline class for treating cancers Download PDF

Info

Publication number
AU2008248475B2
AU2008248475B2 AU2008248475A AU2008248475A AU2008248475B2 AU 2008248475 B2 AU2008248475 B2 AU 2008248475B2 AU 2008248475 A AU2008248475 A AU 2008248475A AU 2008248475 A AU2008248475 A AU 2008248475A AU 2008248475 B2 AU2008248475 B2 AU 2008248475B2
Authority
AU
Australia
Prior art keywords
group
methylene
hydroxyquinoline
substituted
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2008248475A
Other languages
English (en)
Other versions
AU2008248475A1 (en
Inventor
Olivier Blin
Frederic Champavere
Jean-Louis Kraus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOPHARMED A RESPONSABILITE Ltee Ste
Original Assignee
BIOPHARMED SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOPHARMED SARL filed Critical BIOPHARMED SARL
Publication of AU2008248475A1 publication Critical patent/AU2008248475A1/en
Application granted granted Critical
Publication of AU2008248475B2 publication Critical patent/AU2008248475B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2008248475A 2007-03-23 2008-03-25 Derivatives of the aminated hydroxyquinoline class for treating cancers Ceased AU2008248475B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR07/02154 2007-03-23
FR0702154A FR2913976B1 (fr) 2007-03-23 2007-03-23 Derives de la classe des hydroxyquinoleines aminees pour le traitement de cancers.
PCT/FR2008/000399 WO2008135671A2 (fr) 2007-03-23 2008-03-25 Dérivés de la classe des hydroxyquinoléines aminées pour le traitement de cancers.

Publications (2)

Publication Number Publication Date
AU2008248475A1 AU2008248475A1 (en) 2008-11-13
AU2008248475B2 true AU2008248475B2 (en) 2013-10-03

Family

ID=38686734

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008248475A Ceased AU2008248475B2 (en) 2007-03-23 2008-03-25 Derivatives of the aminated hydroxyquinoline class for treating cancers

Country Status (8)

Country Link
US (2) US8324243B2 (https=)
EP (1) EP2139860A2 (https=)
JP (1) JP5555494B2 (https=)
CN (1) CN101641332B (https=)
AU (1) AU2008248475B2 (https=)
CA (1) CA2680803A1 (https=)
FR (1) FR2913976B1 (https=)
WO (1) WO2008135671A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2913976B1 (fr) * 2007-03-23 2013-04-26 Biopharmed Derives de la classe des hydroxyquinoleines aminees pour le traitement de cancers.
EP2149567A1 (en) * 2008-07-18 2010-02-03 Bayer Schering Pharma Aktiengesellschaft Cyclic polyamines for binding phosphatidylserine
FR2940289B1 (fr) * 2008-12-23 2014-09-12 Biopharmed Derives de la classe des hydroxyquinoleines aminees pour le traitement du cancer du pancreas
KR101514285B1 (ko) 2013-08-09 2015-04-22 숙명여자대학교산학협력단 아미노다이하이드로퀴놀린 화합물 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는 암 질환의 예방 또는 치료용 약학적 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5736192A (en) * 1980-08-13 1982-02-26 Nippon Oil Co Ltd Metal inactivator and its composition
IL130324A0 (en) * 1999-06-07 2000-06-01 Yeda Res & Dev Pharmaceutical compositions comprising iron chelators for the treatment of neurodegenerative disorders and some novel iron chelators
US8058442B2 (en) * 2002-11-07 2011-11-15 Technion Research And Development Foundation Ltd. Neuroprotective iron chelators and pharmaceutical compositions comprising them
CN1295218C (zh) * 2004-06-18 2007-01-17 中国科学院广州化学研究所 单官能团8－羟基喹啉金属配合物的烯类单体及其制法和用途
FR2913976B1 (fr) * 2007-03-23 2013-04-26 Biopharmed Derives de la classe des hydroxyquinoleines aminees pour le traitement de cancers.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Kolobielski, M. (1966) J. Hetero. Chem., 3:275-277 *

Also Published As

Publication number Publication date
US8614230B2 (en) 2013-12-24
AU2008248475A1 (en) 2008-11-13
CN101641332A (zh) 2010-02-03
US20130102630A1 (en) 2013-04-25
EP2139860A2 (fr) 2010-01-06
CA2680803A1 (en) 2008-11-13
WO2008135671A3 (fr) 2009-05-22
CN101641332B (zh) 2014-03-12
FR2913976B1 (fr) 2013-04-26
JP5555494B2 (ja) 2014-07-23
JP2010522147A (ja) 2010-07-01
FR2913976A1 (fr) 2008-09-26
US8324243B2 (en) 2012-12-04
WO2008135671A2 (fr) 2008-11-13
US20100120856A1 (en) 2010-05-13

Similar Documents

Publication Publication Date Title
ES2525423T3 (es) Nuevos derivados de poliquinolinas y su utilización terapéutica
TWI837402B (zh) 含氟化合物、含氟化合物之製備方法及其抗癌醫藥用途
JP4464814B2 (ja) アントラニル酸誘導体の水和物の製造方法
WO2016014522A1 (en) Inhibitors of deubiquitinating proteases
AU2008248475B2 (en) Derivatives of the aminated hydroxyquinoline class for treating cancers
Nadysev et al. Aminomethylation of heliomycin: Preparation and anticancer characterization of the first series of semi-synthetic derivatives
US11390591B2 (en) 2,4,6-trisubstituted s-triazine compound, preparation method therefor, and use thereof
US20150328334A1 (en) Molecular containers and methods of making and using same
WO2017175018A2 (en) Mdr-reversing 8-hydroxy-quinoline derivatives
JP6695875B2 (ja) 抗がん剤としての新規な１，３，５−トリアジン系ｐｉ３ｋ阻害剤及びその製造方法
KR20150138153A (ko) 항생 활성을 강화시키는 활성을 가지는 스피로이소옥사졸린 화합물
EP1380574B1 (en) 9-aminoacridine derivates and process for the preparation thereof
ES2924575A1 (es) Derivados de quinolilnitronas para su uso en la prevencion y el tratamiento de la isquemia cerebral, ictus isquemico y enfermedades neurodegenerativas
US20220251124A1 (en) 3,5-bis(phenyl)-1h-heteroaryl derivatives as medicaments
JP6570034B2 (ja) 新規なグルタミン酸誘導体およびその用途
WO2025012634A1 (en) Carbazole compounds and their use in therapy, in the treatment of a respiratory infection
Omar et al. Discovery, optimization, and cellular activities of 2-(aroylamino) cinnamamide derivatives against colon cancer
WO2023238919A1 (ja) ハイブリッド型化合物又はその塩
CN117534658A (zh) 一种靶向降解CK1α蛋白并激活P53蛋白的化合物及其应用
HK40001487B (en) 2,4,6-trisubstituted s-triazine compound, preparation method therefor, and use thereof
CZ305626B6 (cs) Dioxocyklobutenylhydrazony a jejich protirakovinné účinky

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired